Eiger BioPharmaceuticals, Inc.·4

Mar 15, 7:27 PM ET

Glenn Jeffrey S 4

4 · Eiger BioPharmaceuticals, Inc. · Filed Mar 15, 2021

Insider Transaction Report

Form 4
Period: 2021-03-12
Transactions
  • Award

    Common Stock

    2021-03-12+5,00076,355 total
  • Award

    Stock Option (Right to Buy)

    2021-03-12+10,00010,000 total
    Exercise: $9.99Exp: 2031-03-11Common Stock (10,000 underlying)
Holdings
  • Common Stock

    (indirect: By Spouse)
    5,000
  • Common Stock

    (indirect: By son)
    460
  • Common Stock

    (indirect: By Eiger Group International, Inc.)
    151,064
Footnotes (3)
  • [F1]Represents shares underlying Restricted Stock Units award that will vest on the first anniversary of the grant date of March 12, 2021.
  • [F2]Shares are held by Eiger Group International, Inc. ("EGI"). The Reporting Person is the Chief Executive Officer of EGI and has sole power to vote and sole power to dispose of shares directly owned by EGI. The Reporting Person disclaims beneficial ownership of such shares except to the extent of any pecuniary interest therein.
  • [F3]The option vests in equal monthly installments over 12 months measured from March 12, 2021 subject to Reporting Person's continuous service status as of each such date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION